Financhill
Sell
11

ADAP Quote, Financials, Valuation and Earnings

Last price:
$0.23
Seasonality move :
23.87%
Day range:
$0.25 - $0.29
52-week range:
$0.25 - $1.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.36x
P/B ratio:
5.43x
Volume:
3.1M
Avg. volume:
1.8M
1-year change:
-82.64%
Market cap:
$64.3M
Revenue:
$178M
EPS (TTM):
-$0.31

Adaptimmune Therapeutics PLC SEC Filings

Company Filed Form Type Description
ADAP
Adaptimmune Therapeutics PLC
11/08/2023 10-Q 10-Q filing on 11/08/2023 View Form
ADAP
Adaptimmune Therapeutics PLC
08/09/2023 10-Q 10-Q filing on 08/09/2023 View Form
ADAP
Adaptimmune Therapeutics PLC
05/12/2023 10-Q 10-Q filing on 05/12/2023 View Form
ADAP
Adaptimmune Therapeutics PLC
11/08/2022 10-Q 10-Q filing on 11/08/2022 View Form
ADAP
Adaptimmune Therapeutics PLC
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
ADAP
Adaptimmune Therapeutics PLC
05/09/2022 10-Q 10-Q filing on 05/09/2022 View Form
ADAP
Adaptimmune Therapeutics PLC
11/04/2021 10-Q 10-Q filing on 11/04/2021 View Form
ADAP
Adaptimmune Therapeutics PLC
08/09/2021 10-Q 10-Q filing on 08/09/2021 View Form
ADAP
Adaptimmune Therapeutics PLC
05/06/2021 10-Q 10-Q filing on 05/06/2021 View Form
ADAP
Adaptimmune Therapeutics PLC
11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
08/06/2020 10-Q 10-Q filing on 08/06/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
05/28/2020 10-Q 10-Q filing on 05/28/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
05/14/2020 10-Q 10-Q filing on 05/14/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
02/27/2020 10-K 10-K filing on 02/27/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
11/06/2019 10-Q 10-Q filing on 11/06/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
08/01/2019 10-Q 10-Q filing on 08/01/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
05/06/2019 10-Q 10-Q filing on 05/06/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
02/27/2019 10-K 10-K filing on 02/27/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
11/06/2018 10-Q 10-Q filing on 11/06/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
08/02/2018 10-Q 10-Q filing on 08/02/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
05/09/2018 10-Q 10-Q filing on 05/09/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
03/15/2018 10-K 10-K filing on 03/15/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
11/02/2017 10-Q 10-Q filing on 11/02/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
08/03/2017 10-Q 10-Q filing on 08/03/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
05/10/2017 10-Q 10-Q filing on 05/10/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
04/06/2017 10-Q 10-Q filing on 04/06/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
03/13/2017 10-K 10-K filing on 03/13/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
11/10/2016 10-Q 10-Q filing on 11/10/2016 View Form
ADAP
Adaptimmune Therapeutics PLC
08/08/2016 10-Q 10-Q filing on 08/08/2016 View Form
ADAP
Adaptimmune Therapeutics PLC
05/12/2016 10-Q 10-Q filing on 05/12/2016 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Diamondback Energy a Good Stock to Buy?
Is Diamondback Energy a Good Stock to Buy?

Diamondback Energy (FANG) is a lesser-known diamond in the rough…

What Is Hindsight Bias In Investing?
What Is Hindsight Bias In Investing?

You’ve probably heard the expression “hindsight is 20/20.” That saying…

Is Rivian a Good Stock a Buy?
Is Rivian a Good Stock a Buy?

Rivian Automotive (RIVN) had an initial IPO of close to…

Stock Ideas

Buy
58
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
29
UNF alert for Mar 26

UniFirst [UNF] is up 0.24% over the past day.

Sell
30
KEQU alert for Mar 26

Kewaunee Scientific [KEQU] is down 1.45% over the past day.

Buy
82
EPAC alert for Mar 26

Enerpac Tool Group [EPAC] is down 3.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock